Article
Resistance to vincristine in cancerous B-cells by disruption of p53-dependent mitotic surveillance
2023-01-20
Abstract excerpt
The frontline therapy R-CHOP for patients with diffuse large B-cell lymphoma (DLBCL) has remained unchanged for two decades despite numerous phase III clinical trials investigating new alternatives. Multiple large studies have uncovered genetic subtypes of DLBCL enabling a targeted approach. To further pave the way for precision oncology, we perform genome-wide CRISPR screening to uncover the cellular response to...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8509cb5c-5319-58e0-b02c-3c3a1fac0da8
- DOI
- 10.1101/2023.01.19.524713
